AIM ImmunoTech Inc. (HEB) [Rocket]

In millions, except per share items	Jun-30-23	Dec-31-22	Sep-30-22	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21
	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q
Net income		-19.4	-20.9	-18.3	-19.4	-19.1	-17.2	-16.7
Depreciation and amortization [+]		0.3	0.3	0.4	0.6	0.8	0.8	0.7
Depreciation		0.0	0.2	0.4	0.5	0.7	0.6	0.7
Amortization of intangible assets		0.2	0.1	0.1	0.1	0.1	0.1	0.1
Stock-based compensation		1.0	1.0	1.1	1.3	1.6	1.8	1.7
Change in working capital [+]		6.1	3.1	1.9	1.7	1.5	-0.3	-0.5
Accounts receivable						0.0		-0.7
Other current assets		-0.2	1.1	1.5	1.6	1.6	0.0	0.0
Accounts payable		0.2	0.6	0.3	0.2	-0.2	0.2	0.2
Accrued expenses		0.4	1.4	0.1	-0.2	0.0	0.0	-0.2
Other		5.7
Other operating activities		-4.0	0.7	0.7	2.2	1.3	4.0	4.1
Cash from operations		-16.1	-15.8	-14.3	-13.7	-14.0	-11.1	-10.6

Capital expenditures [+]		-0.1	0.0	0.0	0.0	0.0	0.0	0.0
Purchases of property and equipment		-0.1				0.0	0.0	0.0
Sales of property and equipment		3.9	0.3					0.2
Purchases of intangible assets		-0.1	-0.2	-0.2	-0.3	-0.6	-0.7
Sales of short-term investments, net [+]		7.4	7.9	7.7	-1.4	-0.2	-2.2	-11.5
Purchases of short-term investments		-2.7	-22.6	-21.7	-22.1	-22.5	-3.1	-13.1
Sales of short-term investments		10.1	30.5	29.4	20.7	22.3	0.8	1.6
Other cash from investing				-0.1
Cash from investing		11.0	8.0	7.4	-1.5	-0.6	-1.2	-10.4

Issuance of common stock, net			0.2	0.2		13.0	16.1
Other cash from financing								-5.1
Cash from financing		0.1	0.2	0.2	-4.6	8.2	11.1	28.2

Free cash flow		-16.2	-15.8	-14.3	-13.7	-14.0	-11.1	-10.6
Per share (diluted)		($0.33)	($0.33)	($0.30)	($0.29)	($0.30)	($0.26)	($0.26)